Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors.

Klaudia Sapko Anna Jamroz-Wiśniewska Michał Marciniec Marcin Kulczyński Anna Szczepańska-Szerej Konrad Rejdak

Published in: Neurologia i neurochirurgia polska (2020)

Despite numerous studies on the use of biomarkers in the diagnosis of MS, more extensive research is needed to determine the clinical usefulness of these molecules and to develop diagnostic tests applicable in everyday practice. This in turn may result in earlier MS detection, faster implementation of treatment, and better therapeutic effects.

Keyphrases

multiple sclerosis
prognostic factors
primary care
mass spectrometry
healthcare
ms ms
white matter
quality improvement
sensitive detection
fluorescent probe
living cells
real time pcr
loop mediated isothermal amplification
combination therapy